FDA Approves Connetics Corporation's Verdeso Foam For The ...
Connetics Corporation is a specialty pharmaceutical company focused on the development ... Contact: Connetics Corporation Jim Goff, 650-843-2851 (Investor
...
http://www.biospace.com/news_story.aspx?NewsEntityId=30531...
|
News: Connetics Announces Results of Special Stockholders Meeting.
20 Dec 2006 ... Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, ...
http://www.genengnews.com/news/bnitem.aspx?name=10570272...
|
Stiefel Laboratories Completes Acquisition Of Connetics ...
Prior to the acquisition by Stiefel Laboratories, Inc., Connetics was a publicly held specialty pharmaceutical company focused on the development and ...
http://www.biospace.com/news_story.aspx?NewsEntityId=41272...
|
CONNETICS TO ACQUIRE U.S. SORIATANE (ACITRETIN) PRODUCT RIGHTS ...
9 Feb 2004 ... Connetics Corporation is a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for ...
http://www.roche.com/pages/downloads/investor/pdf/praesentat...
|
Connetics Corporation Licenses Technology For The Treatment Of ...
7 Mar 2006 ... (BUSINESS WIRE)--March 7, 2006--Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes ...
http://www.biospace.com/news_story.aspx?NewsEntityId=11828...
|
Board of Directors - Onyx Pharmaceuticals
President and Chief Executive Officer, Onyx Pharmaceuticals, Inc. .... Prior to Connetics, Mr. Wiggans was president and chief operating officer of ...
http://www.onyx-pharm.com/view.cfm/11/Board-of-Directors...
|
{1} Approves {2}'s Evoclin(TM) For Treating Acne - News, Search ...
Connetics Corporation is a specialty pharmaceutical company focused on the development and ... CONTACT: Patrick O'Brien, Director, Investor Relations of
...
http://www.biospace.com/news_story.aspx?NewsEntityId=1782002...
|
BioWorld Today
Founded in 1847, Stiefel is the world's largest independent pharmaceutical company specializing in dermatology. Connetics' 400 employees, including 200 in
...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
Clindamycin/tretinoin: clindamycin phosphate/tretinoin gel.
On 1 April 2005, Yamanouchi merged with Fujisawa to form Astellas Pharma. Connetics has exclusive development and commercialisation rights for ...
http://www.ncbi.nlm.nih.gov/pubmed/15991883...
|
Genentech: Medicines: Medicine Approvals Timeline
Thereafter, Connetics sublicensed, then later assigned, all of its rights to InterMune Pharmaceuticals, Inc. Protropin manufacturing was discontinued at the
...
http://www.gene.com/gene/products/approvals-timeline.html...
|
